Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration – A transdiagnostic study cross‐validating atrophy and fluid biomarkers
Alzheimer's & Dementia · 2024
DOI: 10.1002/alz.13863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Lea Hüper und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany. Hauptthemen laut MEDLINE: Progranulins, Biomarkers, Frontotemporal Lobar Degeneration, Atrophy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Research Foundation, German Federal Ministry of Education and Research, EU Joint Program-Neurodegenerative Disease Research.
Abstract (Originalsprache)
INTRODUCTION Frontotemporal lobar degeneration (FTLD) encompasses behavioral variant frontotemporal dementia (bvFTD), progressive supranuclear palsy, corticobasal syndrome/degeneration, and primary progressive aphasias (PPAs). We cross‐validated fluid biomarkers and neuroimaging. METHODS Seven fluid biomarkers from cerebrospinal fluid and serum were related to atrophy in 428 participants including these FTLD subtypes, logopenic variant PPA (lvPPA), Alzheimer's disease (AD), and healthy subjects. Atrophy was assessed by structural magnetic resonance imaging and atlas‐based volumetry. RESULTS FTLD subtypes, lvPPA, and AD showed specific profiles for neurofilament light chain, phosphorylated heavy chain, tau, phospho‐tau, amyloid beta 1‐42 from serum/cerebrospinal fluid, and brain atrophy. Neurofilaments related to regional atrophy in bvFTD, whereas progranulin was associated with atrophy in semantic variant PPA. Ubiquitin showed no effects. DISCUSSION Results specify biomarker and atrophy patterns in FTLD and AD supporting differential diagnosis. They identify neurofilaments and progranulin in interaction with structural imaging as promising candidates for monitoring disease progression and therapy. Highlights Study cross‐validated neuroimaging and fluid biomarkers in dementia. Five kinds of frontotemporal lobar degeneration and two variants of Alzheimer's disease. Study identifies disease‐specific fluid biomarker and atrophy profiles. Fluid biomarkers and atrophy interact in a disease‐specific way. Neurofilaments and progranulin are proposed as biomarkers for diagnosis and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
- Department of Neurology, University Clinic Halle, Martin Luther University Halle-Wittenberg, Halle, Saale, Germany.
- Clinic for Cognitive Neurology, University Hospital Leipzig, Leipzig, Germany.
- Department of Neurology, Ludwig Maximilians University Munich, Munich, Germany.
- Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.
- kbo-Inn-Salzach-Klinikum, Clinical Center for Psychiatry, Psychotherapy, Psychosomatic Medicine, Geriatrics and Neurology, Wasserburg/Inn, Germany.
Förderung
- German Research Foundation
- German Federal Ministry of Education and Research
- EU Joint Program-Neurodegenerative Disease Research
- Genfi-Prox and Moodmarker
- Sächsische Aufbaubank
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Hüper, L., Steinacker, P., Polyakova, M., Mueller, K., Godulla, J., Herzig, S., Danek, A., Engel, A., Diehl-Schmid, J., Classen, J., Fassbender, K., Fliessbach, K., Jahn, H., Kassubek, J., Kornhuber, J., Landwehrmeyer, B., Lauer, M., Obrig, H., Oeckl, P., …, & Schroeter, M. L. (2024). Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration – A transdiagnostic study cross‐validating atrophy and fluid biomarkers. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13863
Vancouver
Hüper L, Steinacker P, Polyakova M, Mueller K, Godulla J, Herzig S, et al. Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration – A transdiagnostic study cross‐validating atrophy and fluid biomarkers. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13863
BibTeX
@article{Hper2024,
author = {Hüper, Lea and Steinacker, Petra and Polyakova, Maryna and Mueller, Karsten and Godulla, Jannis and Herzig, Sabine and Danek, Adrian and Engel, Annerose and Diehl-Schmid, Janine and Classen, Joseph and Fassbender, Klaus and Fliessbach, Klaus and Jahn, Holger and Kassubek, Jan and Kornhuber, Johannes and Landwehrmeyer, Bernhard and Lauer, Martin and Obrig, Hellmuth and Oeckl, Patrick and Prudlo, Johannes and Saur, Dorothee and Anderl-Straub, Sarah and Synofzik, Matthis and Wagner, Matias and Wiltfang, Jens and Winkelmann, Juliane and Volk, Alexander E and FTLD Consortium Germany, FTLD Consortium Germany and Huppertz, Hans-Jürgen and Otto, Markus and Schroeter, Matthias L},
title = {Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration – A transdiagnostic study cross‐validating atrophy and fluid biomarkers},
journal = {Alzheimer's & Dementia},
year = {2024},
doi = {10.1002/alz.13863}
}
EUVIMED